Order results by:
| Issue | Title | |
| Vol 16, No 3 (2024) | Clinical and neurophysiological features of the augmentation phenomenon in restless legs syndrome | Abstract similar documents |
| N. A. Gorbachev, A. V. Obukhova, L. A. Fedeneva, M. G. Poluektov | ||
| "... medications (p=0.004). In augmentation, the MoCA score is lower (p=0.01), such patients use fewer words ..." | ||
| Vol 13, No 3 (2021) | Validation of a Russian version of the Berg Balance Scale | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, A. A. Zimin, A. B. Zaitsev, K. A. Yatsko, D. A. Melchenko, A. A. Rimkevichus, E. S. Zhirova, A. S. Taratukhina, A. S. Rizvanova, G. A. Gatina, M. E. Kalinkina, M. A. Piradov, K. Berg | ||
| "... points), reliability (Pearson's correlation coefficient r=0.98, р<0.0001; Cronbach's alpha α=0.94 р<0.001 ..." | ||
| Vol 9, No 3 (2017) | Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova | ||
| "... number of NMS per patient with PD was 9.13±4.81 in the study group and 5.43±3.4 in the control group (p<0.001 ..." | ||
| Vol 13, No 2 (2021) | Psychometric properties of the Russian version of the Perth Emotional Reactivity Scale-Short Form | Abstract similar documents |
| P. M. Larionov, E. K. Ageenkova, T. V. Belashina | ||
| "... Краткая форма Пертской шкалы эмоциональной реактивности (Perth Emotional Reactivity Scale – Short ..." | ||
| Vol 9, No 3 (2017) | Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, V. E. Drobakha, N. A. Kaileva, L. I. Syromyatnikova, Yu. A. Golosova, V. V. Shestakov | ||
| "... (MTT) в 10 зонах мозга в соответствии со шкалой ASPECTS (Alberta Score Program Early CT Score ..." | ||
| Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
| "... , порой значительного, времени на их заполнение и последующую обработку. Пятибалльная шкала оценки КЖ у ..." | ||
| Vol 13, No 4 (2021) | IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy | Abstract similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko | ||
| "... 40 до 100 ЕД (min 1,3, max 4,5 ЕД/кг массы тела). Для оценки эффективности лечения применяли Шкалу ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| Vol 16, No 4 (2024) | Validation of the Russian version of Swiss Narcolepsy Scale for narcolepsy type 1 screening | Abstract similar documents |
| A. O. Golovatyuk, A. S. Kuts, A. Yu. Melnikov, A. V. Zaharov, M. G. Poluektov, C. Bassetti | ||
| "... нарколепсии является Шкала нарколепсии Улланлинны (ШНУ; Ullanlinna Narcolepsy Scale), обладающая высокой ..." | ||
| Vol 10, No 4 (2018) | Validation of the modified Rankin Scale in Russia | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, E. S. Zhirova, D. A. Melchenko, A. S. Taratukhina, А. A. Butkovskaya, K. A. Ilyina, A. B. Zaitsev, A. A. Zimin, A. S. Klochkov, R. Kh. Lyukmanov, M. E. Kalinkina, M. А. Piradov, A. M. Kotov-Smolensky, A. E. Khizhnikova | ||
| "... Цель — создание русскоязычной версии модифицированной шкалы Рэнкина (МШР) и оценка ее ..." | ||
| Vol 4, No 1 (2012) | Use of Addenbrooke’s cognitive examination-revised to evaluate the patients’ state in general medical practice | Abstract similar documents |
| Nikolai Nikolayevich Ivanets, D M Tsarenko, M A Bobrova, A A Kursakov, E G Starostina, A E Bobrov | ||
| "... таких больных модифицированной Адденбрукской когнитивной шкалы «Addenbrooke's Cognitive Examination ..." | ||
| Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
| V. E. Medvedev | ||
| "... . For other mental disorders, doctors more frequently added quetiapine to the therapy (23.2%; p<0.001 ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... and anxiety (p < 0.001). Vortioxetine demonstrated an optimal balance between tolerability and clinical ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Cognitive and emotional changes in patients with juvenile myoclonic epilepsy | Abstract similar documents |
| R. V. Magzhanov, D. V. Anisimova, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova | ||
| "... Монреальской шкале оценки когнитивных функций выявлено у 12 (40%) пациенток. Наибольшие трудности пациентки ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
| I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... прогрессирующей неврологической дисфункцией. Для определения тяжести течения РС по существующим шкалам требуется ..." | ||
| Vol 11, No 4 (2019) | Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk | Abstract similar documents |
| V. V. Henkel, A. S. Kuznetsova, A. O. Salashenko, E. V. Lebedev, I. I. Shaposhnik | ||
| "... помощью краткой шкалы оценки психического статуса (КШОПС), у пациентов с высоким и очень высоким ..." | ||
| Vol 11, No 3 (2019) | Back pain and osteoporosis | Abstract similar documents |
| A. I. Isaikin, O. Yu. Isaikina, T. I. Shadyzheva, Yu. M. Shor, M. S. Kachanovsky | ||
| "... М.А. Katbleen. Интенсивность боли определяли по числовой рейтинговой шкале, наличие невропатического ..." | ||
| Online-first | Прогностическая значимость умеренных когнитивных нарушений у пациентов с высоким и очень высоким кардиоваскулярным риском | Abstract similar documents |
| В. В. Генкель, А. С. Кузнецова, А. О. Салашенко, Е. В. Лебедев, И. И. Шапошник | ||
| "... помощью краткой шкалы оценки психического статуса (КШОПС), у пациентов с высоким и очень высоким ..." | ||
| Vol 8, No 1 (2016) | Multiple sclerosis-related fatigue and possibilities of its correction | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... тесты и шкалы. Наиболее распространены шкала Fatigue Severity Scores (FSS) для оценки физической и ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... correlation was established between the total assessment of QoL and the severity of dystonia (r=0.35; p<0.01 ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... .80 ± 1.06 points respectively after 6 months (p < 0.001), reduction in neuropathic pain according to NTSS ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... for the following domains: physical functioning (p<0.01), role-physical functioning (p<0.001), pain intensity (p<0.01 ..." | ||
| Vol 17, No 2 (2025) | Interdisciplinary approach (neurologist and psychiatrist) in the treatment of chronic tension-type headaches | Abstract similar documents |
| K. M. Ashibokova, D. S. Petelin, O. N. Voskresenskaya, B. A. Volel | ||
| "... significant decrease in the number of headache (HA) days 5.0±1.96 (in the control group 11.0±3.66; p<0.01 ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... .80 to 29.6±12.80 points (p<0.001), in the group with PPPD and peripheral vestibular disorders – from 49 ..." | ||
| Vol 14, No 1 (2022) | Validation of the Russian version of Stress and Anxiety to Viral Epidemics – 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic | Abstract similar documents |
| E. S. Mosolova, S. Chung, D. N. Sosin, S. N. Mosolov | ||
| "... стресса и тревоги в условиях эпидемии. Цель исследования – валидация русскоязычной версии шкалы «Стресс и ..." | ||
| Vol 12, No 3 (2020) | Features of the pathogenesis, diagnosis, and treatment of panic attacks in young people | Abstract similar documents |
| M. L. Chukhlovina | ||
| "... and Covey anxiety scale values; Spearman's rank correlation coefficient was 0.681 (p<0.01). The PA severity ..." | ||
| Vol 6, No 3 (2014) | The risk factors and prevention of stroke in atrial fibrillation | Abstract similar documents |
| V. A. Parfenov, S. V. Verbitskaya | ||
| "... проанализированы ФР инсульта при ФП. Отмечается информативность простой в использовании шкалы CHA2DS2-VASc ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... , USA). Results and discussion. We found a significant (p<0.001) decrease in the thickness ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... decreased from 45.59±15.47 to 29.9±12.56 points (p<0.001), the severity of anxiety according to BAI from 27 ..." | ||
| Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
| S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
| "... were significantly higher (p<0.01) in patients with hypertension-mediated organ damage or associated ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... ; 41] to 30 [27; 33] scores by injection cycle 4 (p < 0.001) and to 26 [23; 27] scores by cycle 8 (p<0.01 ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... administration showed a statistically significant reduction in the severity of cognitive impairment (p<0.001 ..." | ||
| Vol 16, No 1 (2024) | Evaluation of the therapeutic efficacy of the drug Cytochrome C in the treatment of asthenia in outpatients (CITRIN study) | Abstract similar documents |
| V. Yu. Lobzin, A. Yu. Emelin, K. A. Kolmakova | ||
| "... , there was a decrease in the severity of asthenia on the MFI-20 scale from 72.2±12.7 to 41.1±12.3 points (p<0.01 ..." | ||
| Vol 8, No 4 (2016) | USE OF AN INFRA-LOW FREQUENCY EEG BIOLOGICAL FEEDBACK TECHNIQUE IN THE COMPREHENSIVE REHABILITATION OF PATIENTS WITH A DECREASED LEVEL OF CONSCIOUSNESS | Abstract similar documents |
| M. V. Shendyapina, S. A. Kazymaev, T. V. Shapovalenko, K. V. Lyadov | ||
| "... A protocol for EEG biological feedback (BFB) at infra-low frequencies (<0.01 Hz) corresponding ..." | ||
| Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... and in 45% in group 2 (p < 0.001). After 18 months of therapy, the clinical effect was observed in 79 ..." | ||
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| "... and their minimal severity were observed in Group 1 in 77.9%; in Group 2 – in 33.7% (p<0.001). Statistically ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... completely (in 42% of participants) or became subclinical (in 48%; р<0.001). CI severity also reduced ..." | ||
| Vol 11, No 1 (2019) | Role of the intact hemisphere in determining the rehabilitation potential in the acute period of ischemic stroke: a diffusion and perfusion model | Abstract similar documents |
| N. A. Kaileva, A. A. Kulesh, N. Kh. Gorst, A. Yu. Bykova, V. E. Drobakha, K. V. Sobyanin, I. N. Shardakov, V. V. Shestakov | ||
| "... NIHSS value (r = 0.55; p < 0.001), the size of a focus (r = 0.42; p < 0.001), FA in the contralateral ..." | ||
| Vol 10, No 2 (2018) | Interventional medicine techniques in the treatment of nonspecific low back pain caused by sacroiliac joint dysfunction | Abstract similar documents |
| A. V. Kavelina, A. I. Isaikin, M. A. Ivanova | ||
| Vol 16, No 5 (2024) | Asthenia and vascular cognitive impairment in young patients after stroke | Abstract similar documents |
| L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva | ||
| "... of treatment, the mean MoCA score was 27.4±1.4 in the main group and 25.9±1.1 in the control group (p<0.01 ..." | ||
| Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
| I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
| "... revealed that Group 1 patients statistically significantly better coped with attention tasks (U=237.0; p<0.001 ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... and exacerbations (p<0.001). MS patients with depression significantly more often (p<0.01) complained of increased ..." | ||
| Vol 10, No 3 (2018) | Median nerve decompression in carpal tunnel syndrome: short- and long-term results | Abstract similar documents |
| A. S. Gilveg, V. A. Parfenov, G. Yu. Evzikov | ||
| "... from 2.76 to 1.15 (p≤0.01) and from 2.72 to 1.24 (p≤0.01), respectively; in Group 2, these dropped from ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... .02), moderate severity of current depression (p<0.02), dizziness among autonomic disorders (p<0.01 ..." | ||
| No 1S (2016): | Analysis of adult patients with epilepsy in the age continuum | Abstract similar documents |
| V. A. Karlov, O. S. Inozemtseva | ||
| "... of anxiety, severity of seizures, and scores of the QOLIE-89 questionnaire (p<0.001). Since the patients ..." | ||
| Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
| D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
| "... effect of the level of inorganic phosphorus (β=5.932; p=0.001) and AP (β=0.055; p=0.025) on the QoL ..." | ||
| Vol 14, No 4 (2022) | Smoking and sleep disorders (population-based study under the WHO “MONICA-psychosocial” program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... – 12.2%) and 78.6% of women (satisfactory sleep – 58.9%, poor sleep – 19.7%; χ2 =38.553; df=2; p<0.001 ..." | ||
| Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
| G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
| "... by 11.6 per month, with monthly injections – by 12.6 per month (p<0.01). In patients who had negative ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... scores of the MoCA (p=0.004), the 12- word recall test (p=0.0003), and the tests of literal (p=0.001 ..." | ||
| Vol 15, No 6 (2023) | Migraine and its childhood equivalents | Abstract similar documents |
| P. V. Zhmyleva, G. R. Tabeeva | ||
| "... .25; -0.004, p=0.0425) and Balashova scale score (ρ =-0.14, 95% CI: -0.26; -0.01, p=0.0327). The mean ..." | ||
| Vol 15, No 4 (2023) | Psychosocial factors and sleep disorders in the population aged 25–64 years in Russia/Siberia (International WHO MONICA-Psychosocial Programme) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. V. Gafarova | ||
| "... of: anxiety (HLA) in 61.8% of men (χ2=56.169; df=4; p<0.001) and 68.1% of women (χ2=36.535; df=4; p<0.001 ..." | ||
| Vol 16, No 3 (2024) | Rhythmic transcranial magnetic stimulation in the treatment of cervical dystonia and comorbid mental disorders | Abstract similar documents |
| A. A. Ragimova, D. S. Petelin, A. N. Galyautdinova, V. A. Tolmacheva, B. A. Volel | ||
| "... stimulation treatment, a significant reduction in anxiety (from 12.2±4.1 to 6.3±2.1 points; p<0.01 ..." | ||
| Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
| T. I. Nasonova, E. V. Parfenova | ||
| "... ; p<0.001), sleepiness according to ESS (8.2±4.6 and 6.2±4.6 points; p=0.014), somatization according ..." | ||
| Vol 17, No 1 (2025) | Emotional disturbances in patients in the remote postoperative period after surgical treatment of cerebral aneurysms | Abstract PDF (Eng) similar documents |
| I. M. Shetova I.M, T. A. Shatokhin, V. A. Luk'yanchikov, A. A. Yakovlev, M. A. Piradov, V. V. Krylov | ||
| "... was found in female patients in the remote postoperative phase of surgical treatment (p<0.001 and p=0 ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| "... ), and age at contracture formation (R=0.60; p=0.001). Analysis of USG and electromyographic findings ..." | ||
| Vol 15, No 3 (2023) | Periarticular cysts of the cervical spine | Abstract similar documents |
| M. G. Bashlachev, G. Yu. Evzikov | ||
| "... .12 points according to VAS (p<0.01), disability according to DI decreased from 51.5±8.08 to 21.25± 4 ..." | ||
| Vol 10, No 3 (2018) | Treatment of patients with acute and subacute dorsalgia | Abstract similar documents |
| O. N. Gerasimova, V. A. Parfenov, E. Yu. Kalimeeva | ||
| "... intensity scores decreased from an average of 6.4 to 1.0; the RMD scores dropped from 6.8 to 1.4 (p<0.001 ..." | ||
| Vol 5, No 3 (2013) | Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins | Abstract similar documents |
| Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva | ||
| "... inventory (11.4±1.4 scores; p=0.001), and an increase in BDNF levels up to 979.71±289.9 pg/ml. Serum ..." | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... , the average score on the Montreal Cognitive Assessment increased from 23.7±3.5 to 25.6±3.9 points (p<0.001 ..." | ||
| Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
| "... with the control group (p<0.001). Anxiety symptoms show a significant dependence on the clinical severity of CD ..." | ||
| Vol 7, No 1 (2015) | Vascular cognitive impairments in chronic kidney disease | Abstract similar documents |
| I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva | ||
| "... –IV than in those with Stages I–II, as shown by the scores of the mini-mental state examination (p<0.001 ..." | ||
| Vol 14, No 5 (2022) | Results of ELBRUS clinical non-interventional study | Abstract similar documents |
| D. O. Rozhkov, K. V. Shevtsova, V. V. Grinyuk, V. A. Parfenov | ||
| "... according to HADS (p<0.001). The duration of treatment was 14.14±3.6 days on average. No adverse events were ..." | ||
| Vol 17, No 1 (2025) | Thrombolytic therapy with Revelisa in ischemic stroke: results of the PRIMA international multicenter observational study | Abstract similar documents |
| N. A. Shamalov, D. R. Khasanova, S. V. Marchenko, M. A. Soldatov, T. P Alekseeva, O. V. Androfagina, L. N. Antipova, L. I. Anishchenko, E. M. Beketova, A. A. Bulanov, A. V. Gerasimova, N. Kh. Gorst, A. G. Gutsalyuk, T. V. Demin, A. V. Dyudin, U. A. Yelemanov, A. R. Zakaryaeva, N. N. Zinovyeva, S. S. Ziborova, D. N. Kazakov, N. V. Komissarova, I. V. Korobeynikov, K. V. Korovashkova, E. L. Kuzmin, A. A. Kulesh, R. R. Kuliev, A. S. Lebedev, A. L. Lukyanov, V. I. Maksimov, O. I. Mikhaylenko, I. V. Moldavskaya, D. M. Murtazalieva, Yu. S. Mukhamadieva, V. N. Nesterova, D. G. Novikov, S. V. Platunova, E. P. Prudius, R. A. Rayemgulov, V. A. Saskin, A. V. Sinelshchikova, E. A. Strautmanis, V. S. Suryakhin, E. V. Tavlueva, Yu. A. Telyatnik, N. V. Halo, M. S. Cherepyansky, N. A. Marskaya | ||
| "... were statistically significant (p<0.001). The hospital mortality rate for the entire group was 8 ..." | ||
| Vol 14, No 2 (2022) | Clinical manifestations and evaluation of cardiac autonomic neuropathy in diabetes mellitus and metabolic syndrome | Abstract similar documents |
| L. S. Moshkhoeva, A. N. Barinov | ||
| "... with deep breathing were comparable to the QAT results (p<0.001). Conclusion. Pulse oximetry can be used ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... to 9 % (p=0.01). After 6 months of dietary enrichment, lower plasma levels of IFNγ were observed ..." | ||
| Vol 13, No 6 (2021) | The effect of sleep duration on the risk of diabetes mellitus in an open population of men aged 45–64 years (international epidemiological studies) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, L. V. Shcherbakova, A. N. Tripelgorn, S. K. Malyutina, O. D. Rymar, S. V. Mustafina, I. V. Gagulin, A. V. Gafarova | ||
| "... <0.001), depression (HR 1.767; 95% CI 1.058–2.952; p<0.05), life exhaustion (HR 1.511; 95% CI 1.266–2 ..." | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... and fulfilling the primary efficacy criterion. A significant (p<0.001–0.009) advantage of the treatment groups ..." | ||
| Vol 9, No 1 (2017) | The impact of sleep-disordered breathing on early functional recovery in ischemic stroke | Abstract similar documents |
| G. M. Lutokhin, L. A. Geraskina, A. V. Fonyakin, M. Yu. Maksimova | ||
| "... deficit (p=0.001) and respiratory disorders (p<0.04) and more frequently large and medium-sized foci (p=0.01 ..." | ||
| 1 - 70 of 345 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
